临床误诊误治2023,Vol.36Issue(10) :139-142.DOI:10.3969/j.issn.1002-3429.2023.10.029

七味肝胆清颗粒联合熊去氧胆酸片治疗慢性胆囊炎的效果及对总胆汁酸、甘胆酸的影响

Effect of Qiwei Gandanqing Granule Combined with Ursodeoxycholic Acid Tablets in the Treatment of Chronic Cholecystitis and Its Effect on Total Bile Acid and Glycocholic Acid

苗园园 吴静 李锐 廖振林
临床误诊误治2023,Vol.36Issue(10) :139-142.DOI:10.3969/j.issn.1002-3429.2023.10.029

七味肝胆清颗粒联合熊去氧胆酸片治疗慢性胆囊炎的效果及对总胆汁酸、甘胆酸的影响

Effect of Qiwei Gandanqing Granule Combined with Ursodeoxycholic Acid Tablets in the Treatment of Chronic Cholecystitis and Its Effect on Total Bile Acid and Glycocholic Acid

苗园园 1吴静 1李锐 2廖振林1
扫码查看

作者信息

  • 1. 071000 河北 保定,保定市第一医院消化内科
  • 2. 071000 河北 保定,陆军第八十二集团军医院中医康复理疗科
  • 折叠

摘要

目的 探讨七味肝胆清颗粒联合熊去氧胆酸片治疗慢性胆囊炎的效果及对总胆汁酸、甘胆酸的影响.方法 选取2021 年1 月—2023 年1 月确诊的86 例慢性胆囊炎为研究对象,按照随机数字表法分为联合组和对照组,每组43 例.联合组给予七味肝胆清颗粒联合熊去氧胆酸片治疗,对照组给予熊去氧胆酸片治疗,连续治疗 1 个月.比较2 组的临床疗效、胆囊功能、总胆汁酸、甘胆酸、炎性因子[C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)]及不良反应.结果 联合组总有效率为95.35%(41/43)高于对照组 74.42%(32/43)(P<0.01).治疗1 个月后,2 组胆囊壁厚度较治疗前缩小,胆囊收缩率较治疗前增加;且联合组胆囊壁厚度小于对照组,胆囊收缩率大于对照组(P<0.05).治疗1 个月后,2 组总胆汁酸、甘胆酸水平较治疗前降低,且联合组低于对照组(P<0.05).治疗1 个月后,2 组血清CRP、TNF-α、IL-6 水平较治疗前降低,且联合组低于对照组(P<0.05).2 组不良反应发生率比较差异无统计学意义(P>0.05).结论 七味肝胆清颗粒联合熊去氧胆酸片可提高慢性胆囊炎患者的治疗效果,改善胆囊功能,减轻炎症反应,且安全系数高.

Abstract

Objective To explore the efficacy of Qiwei Gandanqing granule combined with Ursodeoxycholic Acid tab-lets in the treatment of chronic cholecystitis and its effect on total bile acid and glycocholic acid.Methods A total of 86 pa-tients with chronic cholecystitis diagnosed from January 2021 to January 2023 were selected as the research subjects,and were divided into combination group and control group according to random number table method,with 43 cases in each group.The combination group was treated with Qiwei Gandanqing granules combined with Ursodeoxycholic Acid tablets,and the control group was treated with Ursodeoxycholic Acid tablets for 1 consecutive month.The clinical efficacy,gallbladder function,total bile acid,glycholic acid,inflammatory factor[C-reactive protein(CRP),tumor necrosis factor-α(TNF-α),interleukin-6(IL-6)]and adverse reactions of the two groups were compared.Results The total effective rate of the combination group was 95.35%(41/43),which was higher than that of the control group[74.42%(32/43)](P<0.01).At 1 month after treatment,the thickness of gallbladder wall in the two groups was reduced and the shrinkage rate of gallbladder was increased.The thickness of gallbladder wall in combination group was smaller than that in control group,and gallbladder shrinkage rate was higher than that in control group(P<0.05).At 1 month after treatment,the levels of total bile acid and cholyglycine in the two groups were lower than those before treatment,and lower in the combination group than in the control group(P<0.05).At 1 month after treatment,the serum levels of CRP,TNF-α and IL-6 in the two groups were lower than those before treatment,and lower in the combination group than in the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Qiwei Gandanqing granules combined with Ursodeoxycholic Acid tablets can improve the therapeutic effect of patients with chronic cholecystitis,improve gallbladder function,reduce inflammatory reaction,and have high safety coefficient.

关键词

慢性胆囊炎/七味肝胆清颗粒/熊去氧胆酸片/总胆汁酸/甘胆酸/C反应蛋白/肿瘤坏死因子-α/白细胞介素-6

Key words

Chronic cholecystitis/Qiwei Gandanqing granules/Ursodeoxycholic Acid tablets/Total bile acid/Gly-cocholic acid/C reactive protein/Tumor necrosis factors-α/Interleukin-6

引用本文复制引用

基金项目

河北省卫生健康委员会基金(20191698)

出版年

2023
临床误诊误治
解放军白求恩国际和平医院

临床误诊误治

CSTPCD
影响因子:0.914
ISSN:1002-3429
参考文献量15
段落导航相关论文